Ondero Met (Linagliptin-Metformin) 2.5mg/850mg Tablet
Ondero Met (Linagliptin-Metformin) 2.5mg/850mg Tablet
Price And Quantity
Pack/Packs
50
Pack/Packs
280 INR
Product Specifications
General Medicines
Metformin (850mg) + Linagliptin (2.5mg)
Tablets
Other
Type 2 diabetes mellitus
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Ondero Met 850mg/2.5mg Tablet is to be taken with food.
Women, Adults, Aged Person
Store below 30C
Product Description
Ondero Met (Linagliptin-Metformin) 850mg/2.5mg Tablet is a combination of two medicines that control high blood sugar levels in people with type 2 diabetes mellitus. This helps prevent serious complications of diabetes such as kidney damage and blindness and may reduce your chance of having a heart attack or stroke.
Ondero Met (Linagliptin-Metformin) 850mg/2.5mg Tablet can be prescribed alone or together with other diabetes medications. All diabetes medicines work best when used along with a healthy diet and regular exercise. The dose you are given will depend on your condition, blood sugar levels, and what other medicines you are taking. Taking this medicine with meals helps to reduce the chances of developing an upset stomach.
You should take it regularly, at the same time each day, to get the most benefit. You should not stop this medicine unless your doctor recommends it. It is controlling your blood sugar levels and helping to prevent serious complications in the future. Your lifestyle plays a big part in controlling diabetes. Therefore, it is important to stay on the diet and exercise program recommended by your doctor while taking this medicine.
Trade Information
India
Cash Advance (CA), Cash in Advance (CID), Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Paypal
500 Per Day
10 Days
Contact us for information regarding our sample policy
10 tablets in 1 strip
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa